Currently out of the existing stock ratings of Nathan Weinstein, 33 are a BUY (94.29%), 2 are a HOLD (5.71%).

Nathan Weinstein

Work Performance Price Targets & Ratings Chart

Analyst Nathan Weinstein, employed at AEGIS, carries an average stock price target met ratio of 8.33% that have a potential upside of 6.85% achieved within 21 days on average.

Nathan Weinstein’s has documented 63 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EVGN, Evogene at 12-Sep-2022.

Wall Street Analyst Nathan Weinstein

Analyst best performing recommendations are on ORMP (ORAMED PHARMACEUTICALS).
The best stock recommendation documented was for ORMP (ORAMED PHARMACEUTICALS) at 6/8/2021. The price target of $20 was fulfilled within 62 days with a profit of $6.15 (44.4%) receiving and performance score of 7.16.

Average potential price target upside

ATAI ATAI Life Sciences BV CDTX Cidara Therapeutics DRIO DarioHealth Corp ENVB Enveric Biosciences KTRA Kintara Therapeutics SCYX Scynexis VNRX Volitionrx Ltd IMUX Immunic MDWD Mediwound Ltd ORMP Oramed Pharmaceuticals CMMB Chemomab Therapeutics Ltd DRC ENTX Entera Bio Ltd IINN Inspira Technologies Oxy BHN Ltd ACST Acasti Pharma AVGR Avinger EVGN Evogene KIN Kindred Biosciences

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$13.67 (1027.82%)


1 months 4 days ago

0/4 (0%)

$13.29 (777.19%)



$7.67 (576.69%)

1 years 1 months 9 days ago

0/3 (0%)

$7.1 (373.68%)


1 years 2 months 25 days ago

0/1 (0%)

$17.08 (114.48%)



2 years 2 months 20 days ago

0/2 (0%)

$16.83 (150.67%)



$7.67 (576.69%)


2 years 2 months 21 days ago

0/3 (0%)

$3.91 (76.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Nathan Weinstein?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?